Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents)
  4. Volume 22, Issue 2
  5. Article
Volume 22, Issue 2
  • ISSN: 1871-5257
  • E-ISSN: 1875-6182

Abstract

Introduction

Myeloproliferative neoplasms (MPNs) are divided into BCR-ABL positive Chronic myeloid leukemia (CML) and BCR-ABL negative MPNs including Polycythemia vera (PV), Essential Thrombocythemia (ET) and Primary myelofibrosis (PMF). Evaluation of the Philadelphia chromosome in MPNs is a diagnostic requirement for classic CML.

Case Report

In 2020, a 37-year-old woman with negative cytogenetic testing for Janus kinase2 (JAK2), Calreticulin (CALR), myeloproliferative leukemia virus oncogene (MPL), and positive for BCR-ABL1 mutation with reticular fibrosis in bone marrow was diagnosed as CML. Some years ago, the patient had been diagnosed with PMF with evidence of histiocytic necrotizing lymphadenitis or Kikuchi-Fujimoto disease (KFD). The BCR-ABL fusion gene was initially evaluated which was negative. Then, Cutaneous squamous cell carcinoma (cSCC) was confirmed by Dermatopathologist with palpable splenomegaly and high white blood cell (WBC) count with basophilia. Finally, BCR-ABL was detected positive by the fluorescence hybridization (FISH) and quantitative real-time polymerase chain reaction (qRT-PCR). In fact, the co-occurrence of PMF with CML was identified.

Conclusion

This case study highlighted the importance of some cytogenetic methods in the detection and classification of MPNs. It is recommended that physicians pay more attention to it and be aware of the planning treatment.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chamc/10.2174/1871525721666230614110621
2024-06-01
2024-11-29

  • From This Site

    /content/journals/chamc/10.2174/1871525721666230614110621
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. KoshyJ. AlperinJ. JanaB. MarkowitzA. QianY-W. A case of Philadelphia chromosome positive myeloproliferative neoplasm in a pregnant woman with unusual primary myelofibrosis features.Case reports in hematology2013201370283110.1155/2013/702831
     [Google Scholar]
  2. BhattV.R. Leukemic transformation in essential thrombocythemia.Future Oncol.201410162593260210.2217/fon.14.23925531047
     [Google Scholar]
  3. CottaC.V. Bueso-RamosC.E. New insights into the pathobiology and treatment of chronic myelogenous leukemia.Ann. Diagn. Pathol.2007111687810.1016/j.anndiagpath.2006.12.00217240312
     [Google Scholar]
  4. CurtinN.J. CampbellP.J. GreenA.R. The Philadelphia translocation and pre-existing myeloproliferative disorders.Br. J. Haematol.2005128573473610.1111/j.1365‑2141.2005.05396.x15725099
     [Google Scholar]
  5. LaibeS. TadristZ. ArnouletC. SaintyD. MozziconacciM.J. A myeloproliferative disorder may hide another one.Leuk. Res.20093381133113610.1016/j.leukres.2009.01.03419250672
     [Google Scholar]
  6. MizutaniS. KurodaJ. ShimizuD. HoriikeS. TaniwakiM. Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia.Int. J. Hematol.201091351652110.1007/s12185‑010‑0502‑320146031
     [Google Scholar]
  7. PandeyA. YadavA.K. BarthwalM. TiwariD. GuptaR. CML presenting synchronously with squamous cell carcinoma of cervix: A case report.Indian J Pathol Oncol.20196114614710.18231/2394‑6792.2019.0026
     [Google Scholar]
  8. JonesA.V. KreilS. ZoiK. WaghornK. CurtisC. ZhangL. ScoreJ. SeearR. ChaseA.J. GrandF.H. WhiteH. ZoiC. LoukopoulosD. TerposE. VervessouE.C. SchultheisB. EmigM. ErnstT. LengfelderE. HehlmannR. HochhausA. OscierD. SilverR.T. ReiterA. CrossN.C. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.Blood200510662162216810.1182/blood‑2005‑03‑132015920007
     [Google Scholar]
  9. BaskaynakG. KreuzerK.A. SchwarzM. ZuberJ. AudringH. RiessH. DörkenB. Le CoutreP. Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment.Eur. J. Haematol.200370423123410.1034/j.1600‑0609.2003.00044.x12656746
     [Google Scholar]
  10. RogersH.W. WeinstockM.A. FeldmanS.R. ColdironB.M. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012.JAMA Dermatol.2015151101081108610.1001/jamadermatol.2015.118725928283
     [Google Scholar]
  11. MittalD. GubinM.M. SchreiberR.D. SmythM.J. New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape.Curr. Opin. Immunol.201427162510.1016/j.coi.2014.01.00424531241
     [Google Scholar]
  12. KhieuM. BeauvaisA. MatzR. BersabeA. BrownP. BrownA. FillmanE. HallJ. Aleukemic myeloid leukemia cutis with a kikuchi disease–like inflammatory pattern in myelodysplastic syndrome.South. Med. J.2017110430831310.14423/SMJ.000000000000063428376531
     [Google Scholar]
  13. ShahidS. AlamS.H. HadleyI. An unusual presentation of Kikuchi-Fujimoto disease with recurrent subdural effusion.Cureus2018103e230210.7759/cureus.230229755898
     [Google Scholar]
  14. KidoH. KanoO. HamaiA. MasudaH. FuchinoueY. NemotoM. AraiC. TakedaT. YamabeF. TaiT. KasaharaM. SuzukiK. ShiragaN. SadamotoS. WakayamaM. TakahashiY. IwasakiY. ShibuyaK. UritaY. Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis) with atypical encephalitis and painful testitis: A case report.BMC Neurol.20171712210.1186/s12883‑017‑0807‑428143446
     [Google Scholar]
  15. SrikantharajahM MahendraP VydianathB LoweGC Kikuchi-Fujimoto disease: A rare but important differential diagnosis for lymphadenopathy.Case Reports20142014bcr201420547010.1136/bcr‑2014‑205470
     [Google Scholar]
/content/journals/chamc/10.2174/1871525721666230614110621
Loading
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Blastic Crisis in a Patient with Unusual Primary Myelofibrosis Characteristics; A Case Report
Cardiovasc. Hematol. Agents Med. Chem. 22, 240 (2024); https://doi.org/10.2174/1871525721666230614110621
/content/journals/chamc/10.2174/1871525721666230614110621
/content/journals/chamc/10.2174/1871525721666230614110621
Loading

Data & Media loading...


  • Article Type:     Case Report
Keyword(s): BCR-ABL positive chronic myeloid leukemia; cutaneous squamous cell carcinoma; fluorescence in situ hybridization; histiocytic necrotizing lymphadenitis; myeloproliferative neoplasms; primary myelofibrosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test